You took on risk because you believed you could do better for your patients. So did we.
HCO works with Value-Based Orgs across both respiratory and neurological care. Two programs. One partner. Incentives aligned with yours from day one.
We are clinician-developed, independently validated, and structured to improve your benchmark performance. Our compensation is tied to the savings we generate. If we do not move the needle, we do not get paid.
Asthma and COPD
Reduce ED visits, hospitalizations, and comorbidity cost
Stroke, Parkinson's and TBI
Reduce readmissions and transportation costs, improve function, lower total cost
Asthma and COPD are among the most fixable cost drivers in your Medicare population.
Poorly controlled respiratory disease erodes benchmark performance year after year. This spend is not fixed. Holding Medicare Advantage risk? The same work moves the Star measures your plan partners watch most: readmissions (PCR), transitions of care (TRC), and follow-up after ED visits (FMC). COPD and asthma both count toward FMC.
Additional annual cost per Medicare asthma member when common comorbidities are present. These costs compound directly into your benchmark.
Additional annual cost per Medicare COPD member with common comorbidities. The spend multiplies when diabetes, obesity, hypertension and anxiety are present.
Stroke is among the most expensive conditions in Medicare. Readmissions are the largest driver.
Virtual neurological rehabilitation improves function and reduces total cost of care. We make it accessible regardless of where your members live. Rehab at home also reaches measures your plan partners report: transitions of care, plus Health Outcomes Survey measures like falls risk and physical health.
Average annual Medicare spend for a stroke survivor. Readmission rates remain persistently high, often due to inadequate post-acute care access.
30-day readmission rate for stroke. Much of this is preventable with consistent post-acute rehabilitation and monitoring.
Built for Medicaid value-based arrangements.
We work with organizations managing Medicaid VBC arrangements, particularly where HRSN and equity are part of the performance framework. We start with your state's measure set. Pediatric asthma follow-up (AAF-E) and COPD follow-through (PCE) apply in most states, and both tie directly to quality withholds.
Aligned incentives. Real accountability.
We integrate with your population
You identify the high-cost and rising-risk respiratory and neuro members. We handle outreach, enrollment, and engagement.
We put our fees at risk
A meaningful portion of our compensation is tied to hitting clinical and cost outcomes. If we don't move the needle, we don't get paid in full.
You improve benchmark performance
Fewer ED visits and hospitalizations. Lower total cost. Better quality scores on the measures your contracts pay on: readmissions, follow-up after ED visits, and transitions of care. The ROI is measurable and attributable.
Let's talk about your population.
We work with Value-Based Orgs of all sizes. Two programs, one partner, incentives aligned from day one.